Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M305832200 on November 17, 2003

J. Biol. Chem., Vol. 279, Issue 5, 3434-3438, January 30, 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
279/5/3434    most recent
M305832200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Andreola, F.
Right arrow Articles by De Luca, L. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Andreola, F.
Right arrow Articles by De Luca, L. M.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Mouse Liver CYP2C39 Is a Novel Retinoic Acid 4-Hydroxylase

ITS DOWN-REGULATION OFFERS A MOLECULAR BASIS FOR LIVER RETINOID ACCUMULATION AND FIBROSIS IN ARYL HYDROCARBON RECEPTOR-NULL MICE*

Fausto Andreola{ddagger}, Graham P. Hayhurst§, Gang Luo¶, Stephen S. Ferguson¶, Frank J. Gonzalez§, Joyce A. Goldstein{ddagger}, and Luigi M. De Luca{ddagger}||

From the {ddagger}Laboratory of Cellular Carcinogenesis and Tumor Promotion, §Laboratory of Metabolism, NCI, National Institutes of Health, Bethesda, Maryland 20892 and Laboratory of Pharmacology, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709

Livers of aryl hydrocarbon receptor (AHR)-null mice have high levels of retinoic acid (RA), retinol, and retinyl palmitate. Hepatic accumulation of RA in these mice may be responsible in part for the hepatic phenotype characterized by small liver size and fibrosis. The increased levels of hepatic RA may be due to decreased metabolism of RA to 4-hydroxyretinoic acid. To identify the P450 isoform(s) involved in RA metabolism, liver microsomes from AHR-null and wild-type mice were subjected to Western blotting and probed with antibodies to rat P450s that cross-react with murine forms. Signal intensity in Western blots probed with anti-rat CYP2C6 antibodies correlated with levels of RA 4-hydroxylation. Furthermore, this anti-rat CYP2C6 antibody inhibited RA 4-hydroxylase activity of wild-type mouse liver microsomes to the levels of AHR-null mouse liver. When used to screen a mouse liver cDNA expression library, this antibody exclusively recognized the murine P450 CYP2C39. Catalytic assays of five recombinant mouse CYP2Cs expressed in Escherichia coli revealed that only CYP2C39 was competent for RA 4-hydroxylation (Km = 812.3 nM and Vmax 47.85 (fmol/min/pmol P450)). Real time reverse transcriptase-PCR used to assess the Cyp2C39 mRNA expression showed decreased levels (30%) of this transcript in AHR-null compared with wild-type liver, consistent with decreased protein levels observed by Western blot analysis using an antibody to a CYP2C39-specific peptide. These data show that CYP2C39 catalyzes RA catabolism and thus possibly controls RA levels in mouse liver. Down-regulation of Cyp2C39 is hypothesized to be responsible for the liver phenotype in the AHR-null mouse.


Received for publication, June 3, 2003 , and in revised form, October 27, 2003.

* The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

|| To whom correspondence should be addressed: NCI, Bldg. 37, Rm. 4054C, 37 Convent Dr., Bethesda, MD 20892-4255. Tel.: 301-496-2698; Fax: 301-496-8709; E-mail: luigi_de_luca{at}nih.gov.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
FASEB J.Home page
M. Zhang, P. Hu, C. R. Krois, M. A. Kane, and J. L. Napoli
Altered vitamin A homeostasis and increased size and adiposity in the rdh1-null mouse
FASEB J, September 1, 2007; 21(11): 2886 - 2896.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Arrecubieta, M.-H. Lee, A. Macey, T. J. Foster, and F. D. Lowy
SdrF, a Staphylococcus epidermidis Surface Protein, Binds Type I Collagen
J. Biol. Chem., June 29, 2007; 282(26): 18767 - 18776.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Du, M. M. Neis, P. A. Ladd, and D. S. Keeney
Differentiation-Specific Factors Modulate Epidermal CYP1-4 Gene Expression in Human Skin in Response to Retinoic Acid and Classic Aryl Hydrocarbon Receptor Ligands
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1162 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. Quadro, L. Hamberger, M. E. Gottesman, V. Colantuoni, R. Ramakrishnan, and W. S. Blaner
Transplacental delivery of retinoid: the role of retinol-binding protein and lipoprotein retinyl ester
Am J Physiol Endocrinol Metab, June 1, 2004; 286(5): E844 - E851.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2004 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement